NCT02224664 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease Status COMPLETED Phase PHASE1
NCT02224651 Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions Status COMPLETED Phase PHASE1
NCT02223819 Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy Status COMPLETED Phase PHASE2
NCT02222922 A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02222493 A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). Status COMPLETED Phase PHASE3
NCT02222441 Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991) Status COMPLETED Phase PHASE1
NCT02219048 An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma Status TERMINATED Phase PHASE2
NCT02217813 A Bioequivalence Study Comparing Two Different Tafamidis Formulations Status COMPLETED Phase PHASE1
NCT02216097 A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder Status TERMINATED Phase PHASE2
NCT02215863 Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years Status COMPLETED Phase PHASE4
NCT02215252 A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN) Status COMPLETED Phase PHASE2
NCT02213757 Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH) Status TERMINATED Phase PHASE4
NCT02213263 A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) Status COMPLETED Phase PHASE3
NCT02213250 An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B Status COMPLETED Phase PHASE1
NCT02211261 A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT02208284 A Single Oral Dose Study Of PF-06427878 In Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02207699 Evaluation of the Effect of Benzonatate on QT Intervals Following Single Dose Administration of Benzonatate to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02207504 Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer Status COMPLETED Phase PHASE1